Reni M - Search Results

1

Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.

Silvestris N, Longo V, Cellini F, Reni M, Bittoni A, Cataldo I, Partelli S, Falconi M, Scarpa A, Brunetti O, Lorusso V, Santini D, Morganti A, Valentini V, Cascinu S. Silvestris N, et al. Among authors: reni m. Crit Rev Oncol Hematol. 2016 Feb;98:309-24. doi: 10.1016/j.critrevonc.2015.11.016. Epub 2015 Nov 23. Crit Rev Oncol Hematol. 2016. PMID: 26653573 Review.

2

A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer.

Mercalli A, Sordi V, Formicola R, Dandrea M, Beghelli S, Scarpa A, Di Carlo V, Reni M, Piemonti L. Mercalli A, et al. Among authors: reni m. Br J Cancer. 2007 May 7;96(9):1358-67. doi: 10.1038/sj.bjc.6603726. Epub 2007 Apr 10. Br J Cancer. 2007. PMID: 17426706 Free PMC article.

3

Ependymoma.

Reni M, Gatta G, Mazza E, Vecht C. Reni M, et al. Crit Rev Oncol Hematol. 2007 Jul;63(1):81-9. doi: 10.1016/j.critrevonc.2007.03.004. Epub 2007 May 4. Crit Rev Oncol Hematol. 2007. PMID: 17482475 Review.

4

PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen.

Reni M, Cereda S, Galli L. Reni M, et al. Cancer Lett. 2007 Oct 18;256(1):25-8. doi: 10.1016/j.canlet.2007.04.009. Epub 2007 Jun 11. Cancer Lett. 2007. PMID: 17561341 Review.

5

Primary central nervous system lymphoma.

Ferreri AJ, Reni M. Ferreri AJ, et al. Among authors: reni m. Crit Rev Oncol Hematol. 2007 Sep;63(3):257-68. doi: 10.1016/j.critrevonc.2007.04.012. Epub 2007 Jun 21. Crit Rev Oncol Hematol. 2007. PMID: 17590348 Review.

6

Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.

Mandalà M, Reni M, Cascinu S, Barni S, Floriani I, Cereda S, Berardi R, Mosconi S, Torri V, Labianca R. Mandalà M, et al. Among authors: reni m. Ann Oncol. 2007 Oct;18(10):1660-5. doi: 10.1093/annonc/mdm284. Epub 2007 Jul 28. Ann Oncol. 2007. PMID: 17660490 Free article.

7

A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.

Reni M, Berardi R, Mambrini A, Pasetto L, Cereda S, Ferrari VD, Cascinu S, Cantore M, Mazza E, Grisanti S. Reni M, et al. Cancer Chemother Pharmacol. 2008 Sep;62(4):673-8. doi: 10.1007/s00280-007-0653-y. Epub 2008 Jan 3. Cancer Chemother Pharmacol. 2008. PMID: 18172650

8

Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma.

Mancosu P, Bettinardi V, Passoni P, Gusmini S, Cappio S, Gilardi MC, Cattaneo GM, Reni M, Del Maschio A, Di Muzio N, Fazio F. Mancosu P, et al. Among authors: reni m. Radiother Oncol. 2008 Jun;87(3):339-42. doi: 10.1016/j.radonc.2008.04.007. Epub 2008 May 15. Radiother Oncol. 2008. PMID: 18486253

9

Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience.

Valentini V, Calvo F, Reni M, Krempien R, Sedlmayer F, Buchler MW, Di Carlo V, Doglietto GB, Fastner G, Garcia-Sabrido JL, Mattiucci G, Morganti AG, Passoni P, Roeder F, D'Agostino GR. Valentini V, et al. Among authors: reni m. Radiother Oncol. 2009 Apr;91(1):54-9. doi: 10.1016/j.radonc.2008.07.020. Epub 2008 Aug 30. Radiother Oncol. 2009. PMID: 18762346

10

Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma.

Reni M, Cereda S, Balzano G, Passoni P, Rognone A, Fugazza C, Mazza E, Zerbi A, Di Carlo V, Villa E. Reni M, et al. Cancer. 2009 Jun 15;115(12):2630-9. doi: 10.1002/cncr.24302. Cancer. 2009. PMID: 19353729 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters